Bioxtreme
About
About Bioxtreme
BioXtreme develops robotic systems for upper-limb and hand rehabilitation after stroke, traumatic brain injury and other neurological damage. Its method combines guided movement with controlled error enhancement: the robot applies forces that make selected differences between intended and completed motion more apparent, giving the patient repeated motor-learning practice under therapist supervision.
deXtreme addresses the shoulder, elbow and wider upper limb, while plaXtreme focuses on fingers and the palm. During a session, the system measures motion, applies adaptive forces and records performance as the patient completes interactive tasks. Clinical staff select exercises, set the treatment protocol and review progress; the robot provides repeatable movement assistance and resistance within that plan. BioXtreme has placed systems in rehabilitation settings and has run clinical evaluations with hospital and research partners.
Funding
- 2026-04-21 - Strategic investment - Bioxtreme secures Serra Holding-led strategic investment as total funding reaches USD 15 million
Bioxtreme announced a strategic investment led by Serra Holding and said total funding to date reaches USD 15 million, supporting global expansion and neurorehabilitation robotics development. - source: globenewswire.com
Investors
- Serra Holding - Lead - Angel / Individual - 1 funding event - first seen 2026-04-21
Team
- Eyal Samuel Shachar - CEO - Current operating leader for BioXtreme's rehabilitation robotics platform and error-augmentation approach to neurorehabilitation.
Timeline
Events
- 2026-04-21 - Funding - Bioxtreme secures Serra Holding-led strategic investment as total funding reaches USD 15 million
Bioxtreme announced a strategic investment led by Serra Holding. The company said the investment brings total funding to USD 15 million to date. The financing supports global expansion, stronger operations in the United States and Europe, and continued neurorehabilitation robotics development.
Source - 2026-04-21 - Product Launch - Bioxtreme introduces Plaxtreme robotic hand-rehabilitation system
Bioxtreme introduced Plaxtreme, a robotic rehabilitation device for restoring functional hand movement. The system combines precision robotics, immersive virtual environments, and Bioxtreme's error augmentation technology. Plaxtreme targets grasp, release, grip, pinch, hand opening, and forearm supination recovery.
Source - 2024-06-03 - Deployment - Bioxtreme and Villa Beretta launch Plaxtreme clinical trial for stroke and traumatic brain injury rehabilitation
The trial focuses on stroke and traumatic brain injury patients in sub-acute and chronic phases. The study involves 32 patients under a treatment protocol developed by Villa Beretta staff and Bioxtreme experts.
Source - 2020-02-17 - Regulatory - Bioxtreme receives FDA clearance for DeXtreme rehabilitation robotic device
Bioxtreme's DeXtreme neurorehabilitation robotic device is listed as FDA approved. The listed FDA number is 10062549. The approval date is listed as February 17, 2020.
Source
Relations
Relationships
- Villa Beretta Rehabilitation Research Innovation Institute
Deployment Partner - Joint clinical trial partnership for Plaxtreme stroke and TBI rehabilitation (Villa Beretta RRII).
Context
Shared workflows
- Overture Life
workflow adjacency - Medical Device Automation
- Perceptive Technologies
workflow adjacency - Medical Device Automation
- Inception Robotics
workflow adjacency - Medical Device Automation
- Hesy Tech
workflow adjacency - Medical Device Automation
- Tenomix
workflow adjacency - Medical Device Automation
- Dopl Technologies
workflow adjacency - Medical Device Automation
- RIF Robotics
workflow adjacency - Medical Device Automation
Context tags
- Medical device robotics supplier - Peer Group
- Medical device supplier layer - Stack Layer
- Medical device automation - Workflow
- Healthcare operations - Customer Environment